We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NEW DRUGMAKING TECHNOLOGIES CAN LOWER DEVELOPMENT COSTS, FDA SAYS
NEW DRUGMAKING TECHNOLOGIES CAN LOWER DEVELOPMENT COSTS, FDA SAYS
April 5, 2004
The hesitance of drugmakers to incorporate the latest scientific and technological advances into their manufacturing operations is contributing to the high cost of drug development and the recent decline in new molecular entities (NMEs) approved by the FDA, the agency said in a new report.